A carregar...
Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports on the association of the rifaximin treatment periods with the results of a lac...
Na minha lista:
| Publicado no: | J Korean Med Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Academy of Medical Sciences
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4444477/ https://ncbi.nlm.nih.gov/pubmed/26028929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2015.30.6.757 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|